263 related articles for article (PubMed ID: 18667516)
1. Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells.
Badr G; Bédard N; Abdel-Hakeem MS; Trautmann L; Willems B; Villeneuve JP; Haddad EK; Sékaly RP; Bruneau J; Shoukry NH
J Virol; 2008 Oct; 82(20):10017-31. PubMed ID: 18667516
[TBL] [Abstract][Full Text] [Related]
2. Signatures of protective memory immune responses during hepatitis C virus reinfection.
Abdel-Hakeem MS; Bédard N; Murphy D; Bruneau J; Shoukry NH
Gastroenterology; 2014 Oct; 147(4):870-881.e8. PubMed ID: 25038432
[TBL] [Abstract][Full Text] [Related]
3. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.
Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R
J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288
[TBL] [Abstract][Full Text] [Related]
4. Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence.
Golden-Mason L; Burton JR; Castelblanco N; Klarquist J; Benlloch S; Wang C; Rosen HR
Hepatology; 2006 Nov; 44(5):1098-109. PubMed ID: 17058243
[TBL] [Abstract][Full Text] [Related]
5. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy?
Lee S; Hammond T; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P
Clin Exp Immunol; 2010 Jul; 161(1):118-26. PubMed ID: 20408862
[TBL] [Abstract][Full Text] [Related]
6. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim.
Kurtulus S; Tripathi P; Moreno-Fernandez ME; Sholl A; Katz JD; Grimes HL; Hildeman DA
J Immunol; 2011 May; 186(10):5729-37. PubMed ID: 21451108
[TBL] [Abstract][Full Text] [Related]
8. Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.
Wiegand J; Cornberg M; Aslan N; Schlaphoff V; Sarrazin C; Kubitschke A; Buggisch P; Ciner A; Jaeckel E; Manns MP; Wedemeyer H
Antivir Ther; 2007; 12(3):303-16. PubMed ID: 17591020
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up after successful interferon therapy of acute hepatitis C.
Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
[TBL] [Abstract][Full Text] [Related]
10. Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
Tan WG; Zubkova I; Kachko A; Wells F; Adler H; Sutter G; Major ME
PLoS One; 2017; 12(7):e0181578. PubMed ID: 28732046
[TBL] [Abstract][Full Text] [Related]
11. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus.
Abdel-Hakeem MS; Bédard N; Badr G; Ostrowski M; Sékaly RP; Bruneau J; Willems B; Heathcote EJ; Shoukry NH
J Virol; 2010 Oct; 84(19):10429-35. PubMed ID: 20668076
[TBL] [Abstract][Full Text] [Related]
13. Tetramer enrichment reveals the presence of phenotypically diverse hepatitis C virus-specific CD8+ T cells in chronic infection.
Nitschke K; Flecken T; Schmidt J; Gostick E; Marget M; Neumann-Haefelin C; Blum HE; Price DA; Thimme R
J Virol; 2015 Jan; 89(1):25-34. PubMed ID: 25320295
[TBL] [Abstract][Full Text] [Related]
14. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C.
Urbani S; Boni C; Missale G; Elia G; Cavallo C; Massari M; Raimondo G; Ferrari C
J Virol; 2002 Dec; 76(24):12423-34. PubMed ID: 12438568
[TBL] [Abstract][Full Text] [Related]
15. Persistent hepatitis C virus (HCV) infection impairs HCV-specific cytotoxic T cell reactivity through Mcl-1/Bim imbalance due to CD127 down-regulation.
Larrubia JR; Lokhande MU; García-Garzón S; Miquel J; González-Praetorius A; Parra-Cid T; Sanz-de-Villalobos E
J Viral Hepat; 2013 Feb; 20(2):85-94. PubMed ID: 23301543
[TBL] [Abstract][Full Text] [Related]
16. TCF1
Wieland D; Kemming J; Schuch A; Emmerich F; Knolle P; Neumann-Haefelin C; Held W; Zehn D; Hofmann M; Thimme R
Nat Commun; 2017 May; 8():15050. PubMed ID: 28466857
[TBL] [Abstract][Full Text] [Related]
17. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus.
Gruener NH; Lechner F; Jung MC; Diepolder H; Gerlach T; Lauer G; Walker B; Sullivan J; Phillips R; Pape GR; Klenerman P
J Virol; 2001 Jun; 75(12):5550-8. PubMed ID: 11356962
[TBL] [Abstract][Full Text] [Related]
18. Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo.
Seigel B; Bengsch B; Lohmann V; Bartenschlager R; Blum HE; Thimme R
Gastroenterology; 2013 Feb; 144(2):426-436. PubMed ID: 23142136
[TBL] [Abstract][Full Text] [Related]
19. Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection.
Burke Schinkel SC; Carrasco-Medina L; Cooper CL; Crawley AM
PLoS One; 2016; 11(6):e0157055. PubMed ID: 27315061
[TBL] [Abstract][Full Text] [Related]
20. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
